Scott B. Shappell, MD, PhD


Low-risk prostate cancer well managed with active surveillance

November 01, 2009

Drs. Scott B. Shappell and Leonard S. Marks discuss clinical use of urine PCA3 mRNA testing for prostate cancer.

Clinical use of urine PCA3 mRNA testing

September 01, 2009

Discovery of the prostate carcinoma-specific gene has led to the development of a promising urine-based laboratory test for the disease.